Member Info for chester18

When is the next daytime Satellite image due to land ?
We need to find out where the Scallywag drilling teams have gone and indeed, are they now set up elsewhere?

Chester.

Tomorrows pre-recorded director presentations had better fully explain why it was so necessary to add £30m to the bank account and cause such dilution at 13p per share. With positive lab data on the Covidity platform and an RNS saying that it was backed by the government to progress to Phase 1 trials the SP could have easily reached 30p per share.
In such circumstances that would be the perfect time to raise more funds.

So the BOD do need to spell out in plain English why it was so important that so many shares had to be issued so suddenly.

I voted yes for all the resolutions because of the heart felt plea by the Directors for us PI's to back them up, we've done our bit and I expect to be now fully informed by them as to "why it was so necessary at this time"......................??

Chester.

We can now warmly look forward to 4.00pm on Monday when we can download from the Scancell website the directors virtual presentations.

Some light may be shone onto the recent debacle and we may glean why Vulpes wanted to stop the extra £17.9m from Redmile. Most importantly we will hear from our team leaders where we are and where we are going with £50m in the bank.

Just how large a company can Scancell become, well, our portfolio of probable commercial platforms is quite formidable and there is good reason to believe that the laboratory results can be replicated in the first human clinical trials.

It would not be ridiculous to see the following list being presented by a very large bio-pharma company that was worth many billions of pounds :

Immunobody ........
ModiTope...............
Glycan Mabs...........
AvidiMab.................
Mab 'FG2811' .........
Covidity...................

That is a large body of work and you can understand why the BOD would welcome the extra funding to enable each platform to have its own scientific team, a leader and financial resources. Especially working in the field of cancer while the pandemic is rampant we may need to create our own safe clinical suites to push on in an acceptably safe and controlled way.

We are now just waiting for the company to begin to outline how and when each platform will be progressed......

Chester.

Yep cheers it should be £120m ......

Trying to be positive and erudite has felt at times like being at Trump rally and trying to claim that the Postal Service actually works !!!

Chester.

Excellent result today but I think we were all quietly confident that all resolutions would be passed this time.

Just a couple of things I was lambasted for saying around late August / early September by a few very vocal naysayers' ....

1 ) that I could see the MCap being around £120k by this November.
2 ) that I could see the share price reaching 19p or beyond by November.

for such hideous remarks I was singled out as a Mr Rampy McRampface and told I was guilty of leading novice investors up the garden path to misery....

Just thought I would now claim back my integrity .....

Chester.

First Posted on the 18th Oct. I still believe there is a modicum of plausibility to my post, Post...

"My thought process follows some simple facts and extrapolates to what has motivated Redmile to look at a small £24m MCap British Biotech company. Redmile are a well know and well respected Bio Investment Fund that aids and nurtures early Biotech's and ultimately passes them on to major pharma once the technology has been proven or at least looks very likely to pass phase 3 and become approved.

Point 1 , Our BOD are aware of how big the impact will be on the SP / MCap if MODI1 destroys four different solid tumours in the first two or three months in our first human trial.

Point 2 , BionTech know Scancell very well and have had the opportunity to get a good look inside the science. BionTech are very close to Genentech who are ultimately owned by Roche.

Point 3 , Due to previous failures and ill advised purchases Big Pharma do prefer to pay a premium for a de-risked investments but it has to be in the right technology at the right time.

( Cancer Vaccines were a definitely a 'no no' 10 years ago but are now on the verge of being the new 'have to have' tech for Big Pharma ).

Point 4 , It is Redmile's 'raison d'etre ' is to provide the bridge ( in terms of cash investment ) to help small innovative early biotechnology companies to become the proven de-risked 'low hanging fruit' that Big Pharma are able to purchase.

Point 5 , Redmile probably approached Scancell already knowing what their end game was and who they would tie the other end of the deal to. Nothing they do will be in isolation there will be no 'wing and a prayer' to any of their investment decisions.

My conclusion : if there is an unseen hand at work, we should not be surprised if its someone who knows the company well. For example a company like Genentech, Roche.

This tussle between Vulpes and Redmile is all about the journey forwards and who owns the lions share at 'End Game' for a proven technology.

Chester.

Good afternoon fellow TRX 'Guess the the SP 'Runners and Riders' .

I thought that a quick reminder was in order. There will be an opportunity in January for everyone to refresh their guesstimated price based on any new info we have received from the company.
If there is anyone else who would like to add their name to the list, you are very welcome.

We currently have a total of 27 entries....... The * indicates pledges for a ‘£25 Charity Donation’.
The Charity to be chosen by the 'Winner' who predicts the nearest SP to the actual Closing SP on Friday 1st October 2021.
The average guess at the moment is 1.117p giving an MCap of £78.6m.

JonnyRod. 0.20p
Nomlungu. 0.30p*
Jurado. 0.42p
TheOldBee. 0.62p*
JoeSoap1. 0.68p*
MRK2020. 0.70p
ChrissyDude. 0.83p
Chester. 0.86p*
Stuofthetoon . 0.95p
GinandMilk. 0.97p
KJM100K. 1.01p*
Scoobyrex. 1.08p
DoneK. 1.1p
Andysmi. 1.20p
theAccountant. 1.25p
LunchBoxBill. 1.21p*
Ohmni. 1.27p
HBomb5. 1.28p*
Mark@1973. 1.30p
SC888. 1.31p
Messi10. 1.45p*
Owennoone. 1.48p
Shovel53. 1.57p
Smokey2. 1.68p
Jimjam. 1.70p*
Sandhopper 1.75p
Icecool. 1.99p*

So we have an MCap range from a tiny £ 14m up to a whooping £ 122.5m, may as well say we have a good mix of 'Pessimists and Optimists'.
We have already seen that an 82,000,000 million buy went through at 0.44p so that has to be our minimum benchmark for where we should be without this current surge in the pandemic.

Good luck everyone and try your level best to avoid this dammed Coronavirus.

Chester.

Hi Ruck

We don't know for absolute sure if it is Vulpes or why if it is them, why they are objecting. We haven't had the curtesy of having it all laid out and explained to us PI's.

So your decision to vote or not vote is based on what you think the problem might be.

All I will say is that the CLN's have a 2 year clause and we can get on with a hell of a lot of science in that time frame. You don't need to worry about a possible low ball take over because the proof of the science will determine value. We can't change any of that but we can give Lindy and the Scancell team more than enough cash to pursue all avenues by recruiting who they want and also how many they want in their first team.

But it is your decision to determine which way you vote.

Chester.

It took a couple of days but I have now voted 'For' on all resolutions, my holding is just over .25% so from what I've read on this board the extra votes in favour should be enough to pass the Redmile funding.

The fact remains that it is strange for Vulpes to contest this investment without stating their case to us private investors. As I keep banging on about, something changed between the 27th August ( Cliff's Presentation ) and the day the £30m funding appeared from left field and the 'nailed on' deal dissipated in to the ether.

My gut feeling is that this 'something' was science based........

Chester.

I would hope that this sell off is a bit of nervousness by PI's new to Scancell who only joined on the Covidity news. Also, as had been said some may have sold in the hope to buy back lower if this debacle continues beyond the end of next week.

I know that if the price does retreat I will add to my holding.

Knowlesi I know you like to wind some of us up but I can't see such a drop to anywhere near your suggestion as both Redmile and Vulpes want to be part of the Scancell success once we get to the clinical data. Anything around 10p would be snapped up in my opinion.

All the best

Chester.

Morning cteal

When we were waiting for the FDA approval we all thought that the SP would rise well above 90p on a successful outcome.
So to be honest with the OO at 60p and the ability to increase my holding at roughly 58p this for a long term investment is a bit of a no brainer. Once we hear from Eton Pharma that their sales are underway the sentiment should begin to change.

The Eton deal brings in ongoing revenues and each week that passes brings the possibility of a Chronocort European Approval a little nearer.

The stock markets are all under pressure as investors begin to flee to cash but DNL have an FDA approved drug so if these circumstance bring the SP lower, in my opinion it means its time to find some cash from down the back of the sofa and add a few more. My ultimate target is 100k shares which will take a while but its a goal I hope to achieve.

Chester.

What is the best outcome for us private investors ?

I would say 'get as many platforms into the clinic as soon as possible'.

We know that if MODI1 works in a human trial as well as it has done in humanised mouse models and donate human blood samples, then it will be a blockbuster drug. Why on earth would we want to wait.
Two years is more than enough time to prove the science works. Obviously we then move to Phase 11 and Phase 111 trials but we will not be doing those on our own.

Maybe a huge buy out with complete Phase 1 data. Pay the loan notes off then.

Chester.

We were all surprised by the sudden announcement of a further placing by Redmile and the amount. Was it a ken jerk reaction to something that's happened at Scancell or was it part of an agreed strategy ?

I think it was over and above the initial investment and has caused this current situation. We were about to do our first Mabs deal but instead we got £30m of extra investment, why?

If its not Vulpes objecting then it must be Calculus ++ !!

Chester.

We need to try and unravel the question of why Vulpes are against Redmile having such a large chunk of Scancell.

At the very least this debacle tells us that it probably was not Vulpes who encouraged Redmile to come on board and I refer back to my assumption that there is another guiding hand in the background.

Could it be that Vulpes see the writing on the wall in that Redmiles true path is to enable a sale sooner than Vulpes would like ?

Chester.

On top of this amazing quarterly report we have to factor in that Newcrest and GGP are also 7 to 8 weeks ahead of us so they now know how big that new zone is and maybe how big a pool of gold is lying at 2,000 mts.

Havieron is the gift that just keeps giving ........ well done all Greatlanders big and small....

Chester.

Now we know part of the reason for Radio Silence the other part could be that Scallywag is Havieron's "Doppelganger "........ what price for that..

Chester

We have never had the SP held down so tight before a quarterly update.
The usual pattern seems to have been broken therefore with tonight's update bringing more light on the potential size of Havieron and Scallywag being fastidiously drilled, are we seeing the Perfect Storm?

We can rightly expect the 11th out of 11 fantastic drill results tonight and due to the time taken and the return to some holes with the Diamond Drilling Rig we can also be confident that 'The Kraken' is not solid granite......!!

I expect a rousing RNS from Greatland Gold in the morning followed up by GH on Proactive Investor saying 'see I told you we were only at the beginning of our journey'......

All the best

Chester.

We have never had the SP held down so tight before a quarterly update.
The usual pattern seems to have been broken therefore with tonight's update bringing more light on the potential size of Havieron and Scallywag being fastidiously drilled, are we seeing the Perfect Storm?

We can rightly expect the 11th out of 11 fantastic drill results tonight and due to the time taken and the return to some holes with the Diamond Drilling Rig we can also be confident that 'The Kraken' is not solid granite......!!

I expect a rousing RNS from Greatland Gold in the morning followed up by GH on Proactive Investor saying 'see I told you we were only at the beginning of our journey'......

All the best

Chester.

Hi Phil

My 10k was bought in two 5k lumps one at 94p the other at 95.25p.
I couldn't buy the whole 10k in one go below 97p.

Another committed RENE warrior bought the 10k....

Anyway I'm happy with my holding just wanting to hear the good news about the RP trial or positive lab results for Exosomes, either will do.

Chester.

hi Bojo

I think the next piece of share moving news will come when Eton Pharma announce their first US orders for Alkindi Sprinkle.
They have stated on their website that it will be available at some point in the last quarter 2020.

Chester.